Treatment of hyperphenylalaninemia associated with phenylketonuria (PKU) and primary BH4 deficiencies
Brite
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12286
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12286
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12286